Peptides
Body
Composition
Weight
Management
Recovery & Repair
Reproductive Health
& Tanning
Longevity
& Skin Care
Cognitive
Enhancement
Tesamorelin
Tirzepatide
TB-500
Kisspeptin
GHK-Cu
Selank
Ipamorelin
Semaglutide
BPC-157
Melanotan 2
Epithalon
Semax
CJC-1295
Retatrutide
NAD+
PT-141
DSIP
MOTS-C
5-Amino-1MQ
FRAG 176-191
Hexarelin
MK-677

Ipamorelin: The Complete Guide to Dosage, Benefits, and Research in 2024

1.Ipamorelin Dosage Chart | Quick Breakdown

Purpose Dosage Range Frequency Administration
General Use 200-300 mcg 1-3x daily Subcutaneous injection
Bodybuilding 300-500 mcg 1-2x daily Subcutaneous injection
Research 3-10 mcg/kg 1-2x daily Subcutaneous injection
Anti-Aging 200-300 mcg 1-2x daily Subcutaneous injection
Sleep Enhancement 100-200 mcg 1x daily (before bed) Subcutaneous injection

2. What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide and growth hormone secretagogue. Key points:

  • Composed of 5 amino acids: Aib-His-D-2-Nal-D-Phe-Lys-NH2

  • Molecular weight: 711.868 Da

  • First selective growth hormone secretagogue

  • Stimulates the release of growth hormone without affecting other hormones

  • Discovered in the 1990s by Novo Nordisk researchers

  • Known for its high specificity and low side effect profile compared to other GHRPs

Table of Contents

3. Ipamorelin Mechanism of Action

Ipamorelin works through several mechanisms:

  1. Binds to the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary gland

  2. Stimulates the release of growth hormone-releasing hormone (GHRH)

  3. Promotes the synthesis and release of growth hormone from the pituitary gland

  4. Does not significantly affect cortisol, prolactin, or other hormone levels

  5. Mimics the pulsatile release of natural growth hormone

  6. Enhances the body's natural growth hormone axis without suppressing it

4. Research Applications and Potential Benefits of Ipamorelin

Ipamorelin and Body Composition

  • Potential to reduce body fat by up to 10% in some studies

  • May increase lean muscle mass by 5-10% over 12-16 weeks

  • Could improve overall body composition and muscle-to-fat ratio

Ipamorelin and Recovery

  • May accelerate wound healing by up to 30% in animal studies

  • Potential to enhance recovery from exercise and injuries

  • Shown to increase collagen synthesis in connective tissues

Ipamorelin and Anti-Aging

  • Possible improvements in skin elasticity and thickness by up to 15%

  • Potential to reduce wrinkles and improve overall skin appearance

  • May increase bone mineral density by 2-3% in postmenopausal women

Ipamorelin and Sleep

  • May improve sleep quality and duration by 15-20%

  • Potential to enhance deep sleep phases, crucial for recovery and cognitive function

Ipamorelin and Cognitive Function

  • Possible improvements in memory and mental clarity

  • Potential neuroprotective effects, particularly in age-related cognitive decline

  • May enhance neuroplasticity and neuron regeneration

5.  Ipamorelin Dosage Guide

Dosing Ipamorelin for General Use

  • Typical dose: 200-300 mcg per day

  • Often divided into 1-3 doses

  • Recommended cycle: 8-12 weeks on, 4 weeks off

Dosing Ipamorelin for Bodybuilding

  • Higher dose: 300-500 mcg per day

  • Usually divided into 1-2 doses

  • Best administered post-workout and before bed

  • Cycle length: 12-16 weeks, followed by 4-6 weeks off

Dosing Ipamorelin for Research

  • Dose range: 3-10 mcg per kg of body weight

  • Typically administered 1-2 times daily

  • Duration of studies often ranges from 4-24 weeks

Dosing Ipamorelin for Anti-Aging

  • Recommended dose: 200-300 mcg per day

  • Often administered in the evening to mimic natural GH pulses

  • Long-term cycles of 6 months or more may be used, with regular monitoring

Dosing Ipamorelin for Sleep Enhancement

  • Typical dose: 100-200 mcg before bed

  • Can be used consistently or cycled 5 days on, 2 days off

6.How to Mix and Administer Ipamorelin

  1. Use bacteriostatic water to reconstitute the lyophilized powder

  2. Add water slowly, allowing it to trickle down the side of the vial

  3. Gently swirl the vial to mix, avoid shaking to prevent protein denaturation

  4. Calculate the correct dosage based on concentration (e.g., 1000 mcg/ml)

  5. Use sterile syringes and needles for each injection

  6. Recommended needle size: 29-31 gauge, 1/2 inch length

7.Ipamorelin Administration Methods

Ipamorelin is typically administered via subcutaneous injection:

  • Common injection sites: abdomen (2 inches away from navel), thigh, or upper arm

  • Rotate injection sites to prevent irritation and lipohypertrophy

  • Administer on an empty stomach or at least 2 hours after eating

  • For optimal results, avoid eating for 30-60 minutes post-injection

8. Ipamorelin Combinations and Interactions

Ipamorelin + CJC-1295

  • Popular combination for enhanced GH release

  • Typical dosage: 200-300 mcg of each, administered together

  • May increase GH release by up to 10 times compared to ipamorelin alone

Ipamorelin + GHRP-2 or GHRP-6

  • May provide synergistic effects

  • Dosages should be adjusted when combined (typically 100-200 mcg each)

  • Can lead to more pronounced hunger effects, especially with GHRP-6

Ipamorelin + Sermorelin

  • Combines a GHRP with a GHRH analogue

  • Can potentially mimic natural GH release more closely

  • Typical dosage: 200-300 mcg ipamorelin + 100-200 mcg sermorelin

9. Where to Buy Ipamorelin Online | 2024 Edition

Ipamorelin is typically only available through licensed medical professionals or specialized clinics. Online purchases may be restricted due to legal and safety concerns. Always ensure you're obtaining ipamorelin from a reputable source that provides third-party testing results.

10.  Is Ipamorelin Safe?

Generally considered safe when used as directed, but potential side effects include:

  • Injection site reactions (redness, swelling)

  • Headaches (reported in 10-15% of users)

  • Flushing (5-10% of users)

  • Nausea (less common, 2-5% of users)

  • Increased appetite (may be beneficial for some users)

  • Water retention (typically mild and transient)

Long-term safety data is limited, and use should be monitored by a healthcare professional. Regular blood tests to monitor IGF-1 levels and other health markers are recommended.

11. Is Ipamorelin Legal?

  • Not approved by the FDA for human use

  • Legal status varies by country and jurisdiction

  • Often restricted to research or medical use

  • Banned by WADA for competitive athletes (falls under S2 category: Peptide Hormones, Growth Factors, Related Substances, and Mimetics)

  • In the US, it's legal to possess for research purposes but not for human consumption

  • Always check local laws before purchasing or using ipamorelin

12. Ipamorelin Storage and Handling

  • Store lyophilized powder at room temperature (20-25°C or 68-77°F) away from light

  • Once reconstituted, store in the refrigerator (2-8°C or 36-46°F)

  • Use within 30 days after reconstitution

  • Do not freeze reconstituted ipamorelin

  • Always use sterile techniques when handling

  • Discard any unused reconstituted peptide after 30 days

13. Frequently Asked Questions (FAQ)

How long does it take to see results with ipamorelin?

Results may vary, but some users report noticeable changes within 3-6 months of consistent use. Improved sleep and recovery may be noticed within the first few weeks, while changes in body composition typically take 2-3 months to become apparent.

Can ipamorelin be used for weight loss?

While not primarily a weight loss drug, ipamorelin may contribute to fat loss as part of its effects on body composition. Studies have shown a potential reduction in body fat percentage of 5-10% over 3-6 months of use.

Is ipamorelin safe for long-term use?

 Long-term safety data is limited. Use should be monitored by a healthcare professional. Some studies have shown safe use for up to 12 months, but regular health check-ups and blood tests are recommended.

Can women use ipamorelin?

Yes, ipamorelin can be used by women. Some studies suggest it may be particularly beneficial for postmenopausal women in terms of body composition and bone density. However, it should not be used during pregnancy or breastfeeding.

Does ipamorelin need to be cycled?

While some protocols suggest cycling (e.g., 12 weeks on, 4 weeks off), others propose longer-term use under medical supervision. The need for cycling may depend on individual response and health markers.

14. Ipamorelin Dosage | Final Verdict

  • Ipamorelin shows promise as a selective growth hormone secretagogue with potential benefits for body composition, recovery, and anti-aging. The typical dosage range of 200-500 mcg per day appears effective for most applications, with specific dosages tailored to individual goals and responses.

  • Its high specificity for growth hormone release and low side effect profile make it an attractive option for those seeking the benefits of increased GH without some of the risks associated with other peptides or exogenous GH administration.

  • However, its use should be approached cautiously due to limited long-term safety data and varying legal status. Always consult with a healthcare professional before starting any peptide regimen, and ensure regular monitoring of health markers during use.

  • As research continues, our understanding of ipamorelin's full potential and optimal use protocols may evolve. Stay informed about the latest studies and guidelines to make the most informed decisions about ipamorelin use.

15. References

  1. Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552-561.

  2. Svensson J, et al. (1998). The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. Journal of Endocrinology, 159(1), 149-154.

  3. Jimenez-Reina L, et al. (2002). Evaluation of growth hormone (GH) secretion and the effects of GH replacement therapy in adults with GH deficiency. Medicina Clinica, 118(11), 401-410.

  4. Kojima M, Kangawa K. (2005). Ghrelin: structure and function. Physiological Reviews, 85(2), 495-522.

  5. Sigalos JT, Pastuszak AW. (2018). The Safety and Efficacy of Growth Hormone Secretagogues. Sexual Medicine Reviews, 6(1), 45-53.

  6. Granata R, et al. (2007). Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology, 148(2), 512-529.

  7. Khorram O, et al. (1999). Activation of the growth hormone (GH) axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. Journal of Clinical Endocrinology & Metabolism, 84(8), 2920-2926.

  8. Veldhuis JD, et al. (2001). Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. Journal of Clinical Endocrinology & Metabolism, 86(11), 5465-5473.

  9. Ghigo E, et al. (1994). Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine, 3(1), 21-26.

  10. Van Cauter E, et al. (1997). Reciprocal interactions between the GH axis and sleep. Growth Hormone & IGF Research, 7(Suppl A), 47-54.

  11. Copinschi G, et al. (1997). Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiency. Journal of Clinical Endocrinology & Metabolism, 82(7), 2017-2023.

  12. Aberg ND, et al. (2006). Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. Journal of Neuroscience, 26(34), 8854-8862.

  13. Nyberg F, Hallberg M. (2013). Growth hormone and cognitive function. Nature Reviews Endocrinology, 9(6), 357-365.

  14. Merriam GR, et al. (2003). Growth hormone releasing hormone and growth hormone secretagogues in normal aging. Endocrine, 22(1), 41-48.

  15. Giustina A, Veldhuis JD. (1998). Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews, 19(6), 717-797.

  16. Sigalos JT, Pastuszak AW. (2018). The Safety and Efficacy of Growth Hormone Secretagogues. Sexual Medicine Reviews, 6(1), 45-53.

  17. Corpas E, et al. (1993). Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. Journal of Clinical Endocrinology & Metabolism, 77(2), 522-527.

  18. Steiger A. (2007). Neurochemical regulation of sleep. Journal of Psychiatric Research, 41(7), 537-552.

  19. Veldhuis JD, Bowers CY. (2010). Human GH pulsatility: an ensemble property regulated by

Disclaimer

Peptideresearcher.com contains information about products intended for research and laboratory use only, unless otherwise explicitly stated. All content is for educational purposes and is not meant to substitute for professional medical advice. Peptideresearcher.com strives to ensure that all information presented is accurate and complies with national and international standards, but it is not guaranteed. The content provided is not intended to diagnose, treat, cure, or prevent any disease or condition.

Peptideresearcher.com does not offer medical diagnoses or prescriptions. Any product information shared is solely for research purposes and should be used by qualified professionals only. We advise all users to consult with a healthcare professional before using any peptides, supplements, or medications mentioned on this site. All opinions expressed are those of the individual authors and may not reflect the opinions of Peptideresearcher.com.

Copyright 2024 - Peptide Researcher

Your access to Peptideresearcher.com is subject to our Terms of Use